Legal Notice

本网站的所有内容由Natus医药公司拥有和控制, and is protected by copyright laws worldwide. 在这个网站上使用的字体是在Apache许可证版本2下授权的.0 found at http://www.apache.org/licenses/LICENSE-2.0. 从本网站下载内容只能用于非商业个人目的, 不允许对内容进行任何修改或进一步复制. 否则,内容可能不会被复制或以任何方式使用.

纳图斯医疗公司将使用实际的努力在这个网站上包括当前和准确的信息. However, we make no representations, warranties, or guarantees as to the accuracy, timeliness, 或此处提供的资料是否完整. Natus医疗有限公司不承担任何损害或伤害造成您的访问, or inability to access, this website, 或避免依赖本网站所提供的任何资料.

此处可能包含其他网站的链接或引用, 但Natus Medical Incorporated对任何其他网站的内容不承担任何责任,也不会对此类内容所引起的任何损害或伤害负责. 任何与其他网站的连结,只供本网站的使用者使用.

本网站包含根据1933年证券法第27A条和1934年证券交易法第21E条对Natus医疗公司的前瞻性陈述. These statements include, among other things, statements concerning our expectations, beliefs, plans, intentions, future operations, financial condition and prospects, and business strategies. The words "may," "will," "continue," "estimate," "project," "intend," "believe," "expect," "anticipate,和其他类似的表达通常识别前瞻性陈述. 前瞻性声明在ag8集团只为非凡享受的网站上包括, but are not limited to, statements regarding the following: our ability to service our debt; our effective tax rate in 2006; the cost of equity-based compensation under SFAS 123R, ag8集团只为非凡享受对未来盈利能力和产生正营运现金流的预期, ag8集团只为非凡享受产品的有效性和优势, 与ag8集团只为非凡享受产品的需求和经济优势有关的因素, ag8集团只为非凡享受计划开发和获得更多的技术, products or businesses; our expectation regarding growth in international sales; our marketing, technology enhancement and product development strategies; our intention to enter into agreements with group purchasing organizations; our intention to introduce new products and extend existing product lines; our intention to seek strategic partners; our belief that we bring products to market efficiently; development of technologies into successful products; our estimate of the length of time for patents to issue; identity of our competition and factors for competition; our compliance with regulatory requirements and laws; and our plan to seek approval to sell our products in additional countries.

前瞻性陈述并不能保证未来的表现,而且可能存在重大的风险和不确定性,这些风险和不确定性可能导致前瞻性陈述所预测的实际结果, 以及ag8集团只为非凡享受未来的财务状况和经营结果, 与ag8集团只为非凡享受过去的结果或目前预期的结果有重大差别. 投资者应仔细审阅本公司截至十二月三十一日止年度报表中“风险因素”标题下的资料, 及于表格10-Q的季度报告内, 以及纳图斯不时向美国证券交易委员会提交的其他报告. 所有前瞻性陈述均以发表该等陈述当日ag8集团只为非凡享受所能获得的资料为依据, ag8集团只为非凡享受没有义务更新前瞻性陈述.

Trademarks, 本网站显示的标志和服务标志是Natus Medical Incorporated的注册商标和未注册商标, its licensors or content providers, or other third parties. 所有这些商标、标志和服务标志都是其各自所有者的财产. 本网站上的任何内容均不得解释为准许, by implication, estoppel, or otherwise, any license or right to use any trademark, 未经所有者事先书面许可,在本网站上展示的标志或服务标志, except as otherwise described herein. Natus保留所有未明确授予的权利和网站及其内容. This site and all of its content, including but not limited to text, design, graphics, interfaces and code, and the selection and arrangement thereof, 作为汇编受到美国和其他国家版权法的保护.

在本网站的电子通讯中,任何可识别个人身份的信息均受本网站的隐私政策管辖. Natus医疗公司有权在任何此类通信中使用所有其他信息, including any ideas, inventions, concepts, techniques or know-how disclosed therein, for any purposes. 此类目的可能包括向第三方和/或发展中国家披露, 制造和/或销售商品或服务.

向纳图斯医疗公司发送信息的人, through this website or by any other manner, 应独自对其中所包含的内容和信息负责, including its truthfulness and accuracy.